Bank of New York Mellon’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,455,590
Closed -$197M 4401
2016
Q4
$197M Sell
2,455,590
-74,784
-3% -$5.94M 0.06% 345
2016
Q3
$202M Buy
2,530,374
+37,503
+2% +$3.03M 0.06% 334
2016
Q2
$194M Sell
2,492,871
-88,023
-3% -$6.28M 0.06% 330
2016
Q1
$142M Sell
2,580,894
-78,535
-3% -$4.28M 0.04% 406
2015
Q4
$164M Sell
2,659,429
-113,754
-4% -$7.17M 0.05% 366
2015
Q3
$175M Sell
2,773,183
-37,733
-1% -$2.69M 0.05% 356
2015
Q2
$205M Sell
2,810,916
-149,871
-5% -$10.8M 0.06% 352
2015
Q1
$194M Sell
2,960,787
-418,234
-12% -$27.8M 0.05% 387
2014
Q4
$220M Sell
3,379,021
-59,649
-2% -$3.84M 0.06% 355
2014
Q3
$207M Sell
3,438,670
-131,990
-4% -$8.62M 0.06% 348
2014
Q2
$247M Sell
3,570,660
-93,289
-3% -$6.05M 0.07% 308
2014
Q1
$240M Buy
3,663,949
+631,559
+21% +$41.1M 0.07% 307
2013
Q4
$188M Sell
3,032,390
-1,442,285
-32% -$83.5M 0.05% 366
2013
Q3
$240M Sell
4,474,675
-402,317
-8% -$20.7M 0.07% 288
2013
Q2
$223M Buy
+4,876,992
New +$211M 0.07% 292

Other funds holding STJ

Bank of New York Mellon's STJ Position: Q1 2017 in Review

Bank of New York Mellon sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,455,590 shares — an estimated $197M sold.

Bank of New York Mellon first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $247M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Bank of New York Mellon reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 2,455,590 St Jude Medical shares in Q1 2017, an estimated $197M.
  • Bank of New York Mellon first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Bank of New York Mellon's St Jude Medical position peaked at $247M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bank of New York Mellon's 13F filing for Q1 2017, filed 3 May 2017.